The transactions highlight Broadwood Partners' continued confidence in STAAR Surgical (NASDAQ:STAA), a company known for its ...

Stifel Nicolaus analyst Thomas Stephan has maintained their bullish stance on STAA stock, giving a Buy rating on January 7.Stay Ahead of the ...

On January 17, BROADWOOD PARTNERS LP, 10% Owner at Staar Surgical STAA executed a significant insider buy, as disclosed in the latest SEC filing.

Canaccord Genuity analyst John Young CFA has maintained their neutral stance on STAA stock, giving a Hold rating yesterday.Stay Ahead of the ...

STAAR Surgical (NASDAQ:STAA – Get Free Report)‘s stock had its “hold” rating reiterated by investment analysts at Needham & Company LLC in a research report issued on Tuesday,Benzinga reports.

LAKE FOREST, Calif., January 13, 2025--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision ...

Get to Know Staar Surgical Better Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...